Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Scripps Research Leading International Partnership For HIV Vaccine

NIH Division Will Provide Grant of $129 Million

An international partnership led by Scripps Research on July 10 pulled in a $129 million grant to bring a potential HIV vaccination into clinical testing.

Tease photo

These San Diego Biotechs Fell Hard, But Managed to Bounce Back

Biotechs recover momentum after being written off

Once pegged as goners, San Diego life sciences companies like Neurocrine, Arena Pharmaceuticals and Tandem Diabetes Care made comebacks. Their stories shed light on how to weather an industry in which companies expand and contract like an accordion based on clinical trial results.

Tease photo

Palomar, Graybill Medical Look at Possible Affliation

Graybill Medical Group and Palomar recently agreed to negotiate a formal affiliation agreement, a move that Palomar says isn’t so much about competition but nonetheless could ripple through North County’s health-care landscape.

Tease photo

Illumina Expands Startup Accelerator Program to the U.K.

An Illumina program that mentors and invests in early-stage genomics companies is expanding to the U.K.

Startups Claim Slice of a Changing Medical Device Market

HEALTH: $800 Billion Market Is Expected By 2030

The news coming out of San Diego’s medical device scene usually centers on the big dogs: Dexcom, ResMed and Nuvasive.

Alliance Healthcare Foundation Hires New Executive Director

Sarah Lyman has been hired as the executive director of the Alliance Healthcare Foundation, a nonprofit that provides grants to nonprofits that boost health care access for those in need.

Cradle Genomics Lands $17.1M Series A Round for Prenatal Testing

A startup led by former Illumina executives that wants to advance prenatal testing recently landed a $17.1 million series A round.

Trefoil Therapeutics Secures $28M Series A Round

San Diego biotech Trefoil Therapeutics recently brought in a $28 million series A round for work on vision diseases.

Analysts Stick By Illumina After Stock Sell-Off

Illumina analysts are still bullish on the company after a lowered revenue estimate prompted a stock sell-off.

StemoniX’s Growth Pushes It Into New Larger Facility

Its microOrgan Platform Provides More Human-Like Testing Opportunities

StemoniX — a San Diego biotech that grows micro organs from stem cells for drug testing — moved into a larger research facility this month.

Tease photo

More stories >>